Alembic Pharmaceuticals announces USFDA final approval for Nelarabine injection, 250 mg/50 mL (5 mg/mL) (Single-Dose Vial) Read more
Successful completion of USFDA inspection at Alembic Pharma Oral Solid Formulation Facility (F-I) at Panelav Read more
Alembic gains USFDA final approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg Read more
Gland Pharma receives tentative USFDA approval for Latanoprostene Bunod Ophthalmic Solution Read more
Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg Read more
Lupin receives tentative approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride tablets Read more